Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CEGX vs LABX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CEGX Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

CEGX Overall Winner 6-Pillar Tally: CEGX 0 – 0 LABX (6 Tie) Matrix Metrics: CEGX 2 – 1 LABX

As of Nov 17, 2026, Tradr 2X Long CEG Daily ETF (CEGX) is the stronger overall head-to-head candidate over Tradr 2X Long ALAB Daily ETF (LABX) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CEGX carries a Unified Composite Score of 34.2/100 (SELL) at $12.34 (N/M Forward P/E, N/A operating margin), whereas LABX carries 52.0/100 (HOLD) at $4.15 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While LABX currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. CEGX 34.2/100 SELL), CEGX captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: CEGX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.1); meanwhile LABX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CEGX vs LABX
CEGX Cboe BZX Head-to-Head Winner
Tradr 2X Long CEG Daily ETF
Institutional Equity
$12.34
-4.86% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.22β · 118% Vol
Unified Composite Score
34.2 / 100 SELL
Tech 10.0 Fund 39.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 50.1 · SMA20: $11.81 · SMA50: $12.65
LABX Cboe BZX
Tradr 2X Long ALAB Daily ETF
Institutional Equity
$4.15
+4.27% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 8.01β · 248% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 53.0 Fund 55.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -17.2%), weak momentum, RSI 34
RSI-14: 34.5 · SMA20: $6.20 · SMA50: $10.11

6-Pillar Scorecard Institutional Category Breakdown (CEGX 0 – 0 LABX)

Columns: Metric · CEGX · LABX
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 81.9% (5th %ile) 141.0% (3rd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CEGX (2) vs LABX (1)
Institutional Metric CEGX LABX Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
13% ($9–$33) 0% ($3–$234) Stronger Trend CEGX
Beta / 30D Volatility
Risk Regime
2.22β · 118% Vol 8.01β · 248% Vol Lower Realized Risk CEGX
Unified Institutional Score
Composite Signal
34.2 / 100 (SELL) 52.0 / 100 (HOLD) Higher Composite LABX
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CEGX +58.39 pp
CEGX: +2.49% · LABX: -55.9%
3M Horizon CEGX +51.18 pp
CEGX: -10.71% · LABX: -61.89%
6M Horizon CEGX +85.87 pp
CEGX: -7.77% · LABX: -93.64%
1Y Horizon CEGX +14.18 pp
CEGX: -53.57% · LABX: -67.75%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CEGX vs LABX. Trailing 12-month operating profitability (CEGX N/A vs LABX N/A) and valuation multiples (CEGX N/M vs LABX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CEGX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
LABX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CEGX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 81.9%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CEGX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LABX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 141.0%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LABX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CEGX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LABX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CEGX vs LABX Key Questions & Quantitative Answers

As of Nov 17, 2026, Tradr 2X Long CEG Daily ETF (CEGX) is the stronger overall head-to-head candidate over Tradr 2X Long ALAB Daily ETF (LABX) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CEGX carries a Unified Composite Score of 34.2/100 (SELL) at $12.34 (N/M Forward P/E, N/A operating margin), whereas LABX carries 52.0/100 (HOLD) at $4.15 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While LABX currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. CEGX 34.2/100 SELL), CEGX captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: CEGX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.1); meanwhile LABX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CEGX and LABX split Growth & Scale metrics: CEGX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with LABX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CEGX generates N/A in USD-normalized revenue versus N/A for LABX. In operating R&D and SG&A reinvestment, CEGX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LABX.

CEGX and LABX trade at balanced relative valuation multiples. CEGX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas LABX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CEGX (N/A ROE) versus LABX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CEGX carries 81.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.22β · 118% Vol realized risk). By comparison, LABX carries 141.0% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (8.01β · 248% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.